US Patent 8232102 Gene delivery
Patent 8232102 was granted and assigned to nanoTherics on July, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+374 characters)
Article
Patent abstract
The present invention relates to a method of delivery of a therapeutic agent to a target cell the method comprising targeting particles comprising the therapeutic agent to the cell using magnetic means to apply a magnetic force to said particles so as to tend to move said particles towards said magnetic means and at the same time moving said magnetic means.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher D. Batich0
Jon Dobson0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08232102 Gene delivery US Patent 8232102 Gene delivery
Infobox
Patent Number
082321020
Patent Number
82321020
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082321020
Date of Patent
July 31, 2012
0Patent Application Number
119121980
Date Filed
April 21, 2006
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08232102 Gene delivery
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08232102
Date of patent
July 31, 2012
Patent application number
11912198
Date Filed
April 21, 2006
Patent primary examiner
Find more entities like US Patent 8232102 Gene delivery
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
